NCT03051659 A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT03032107 A Study Of Pembrolizumab In Combination With Trastuzumab-DM1 Status COMPLETED Phase PHASE1
NCT03020030 Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02981940 A Study of Abemaciclib in Recurrent Glioblastoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02978443 A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab Status TERMINATED Phase PHASE2
NCT02976103 Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket Status COMPLETED Phase NA
NCT02974647 Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma Status RECRUITING Phase PHASE2
NCT02956473 Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy Status COMPLETED Phase NA
NCT02950987 Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes Status ACTIVE_NOT_RECRUITING Phase NA
NCT02943642 Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides Status WITHDRAWN Phase PHASE2
NCT02943590 STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines) Status COMPLETED Phase PHASE2
NCT02926911 Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS Status ACTIVE_NOT_RECRUITING Phase NA
NCT02926729 Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy Status RECRUITING Phase NA
NCT02919683 Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity Status ACTIVE_NOT_RECRUITING Phase PHASE2